Galectin-1 is associated with hematopoietic cell engraftment in murine MHC-mismatched allotransplantation
Haploidentical hematopoietic cell transplantation (haplo-HCT) is associated with an increased risk of allograft rejection. Here, we employed a major histocompatibility complex (MHC)-mismatched allogeneic HCT (allo-HCT) murine model to better understand the role of Gal-1 in immune tolerance. Transpla...
Saved in:
Published in | Frontiers in immunology Vol. 15; p. 1411392 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
16.09.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 1664-3224 1664-3224 |
DOI | 10.3389/fimmu.2024.1411392 |
Cover
Summary: | Haploidentical hematopoietic cell transplantation (haplo-HCT) is associated with an increased risk of allograft rejection. Here, we employed a major histocompatibility complex (MHC)-mismatched allogeneic HCT (allo-HCT) murine model to better understand the role of Gal-1 in immune tolerance. Transplanted mice were classified into either rejected or engrafted based on donor chimerism levels. We noted significantly higher frequencies of CD4
+
T cells, CD8
+
T cells, natural killer cells, IFN-γ and TNF-α producing CD4
+
T cells, and IFN-γ producing dendritic cells and macrophages in rejected mice. Conversely, we found significantly increased frequencies of regulatory T cells (Tregs), predominantly Helios
+
, IL-10-producing CD4
+
T cells, type 1 regulatory (Tr1) cells, and the proportion of Tr1
+
Gal-1
+
cells in engrafted mice. Further, Gal-1 specific blockade in Tregs reduced suppression of effector T cells in engrafted mice. Lastly, effector T cells from engrafted mice were more prone to undergo apoptosis. Collectively, we have shown that Gal-1 may favor HSC engraftment in an MHC-mismatched murine model. Our results demonstrate that Gal-1-expressing Tregs, especially at earlier time points post-transplant, are associated with inducing immune tolerance and stable mixed chimerism after HCT. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Nicolaus Kröger, University Medical Center Hamburg-Eppendorf, Germany Elias Toubi, Technion Israel Institute of Technology, Israel These authors have contributed equally to this work Reviewed by: Teresa Lopes Ramos, Luxembourg Institute of Health, Luxembourg |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2024.1411392 |